The company and its Research & Development activities to tackle antimicrobial resistance, infectious and respiratory disease was highlighted in a recent report by Healthcare UK, a joint initiative of the Department of Health and Social Care, NHS England and the Department for Business and Trade. Healthcare UK champions the UK healthcare sector to foster opportunities and bolster international business growth.
Recent Posts
- NovaBiotics Pharma Division Highlighted in Healthcare UK report
- NovaBiotics announces move to ONE BioHub
- NovaBiotics Consumer Health Signs Global Sales and Distribution Agreement for its Breakthrough Nail Health Solution, Tinexyl®.
- TinexylPRO Launched at Key Industry Events
- Appointment of Dr Trevor Phillips to the Board of NovaBiotics
Recent Comments